Rosetta Genomics (Israel)
Rosetta Genomics Ltd. was a molecular diagnostics company with offices in Israel and the United States that uses micro-ribonucleic acid biomarkers to develop diagnostic tests designed to differentiate between various types of cancer. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Rosetta Genomics (Israel), Israel, covering academic research published from 2002 to 2020. Read More.
Open Access Percentage
42%
Total
Publications
97
Total Open
Publications
41
Total
Citations
13K
Open Access
Percentage
42%
Total
Publications
97
Total Open
Publications
41
Total
Citations
13K
Breakdown
Publisher Open
25%
Both
16%
Other Platform Open
2%
Closed
57%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
19
Hybrid 15%
6
No Guarantees 37%
15
Other Platform Open
Domain 61%
11
Other Internet 39%
7
Public 11%
2
Institution 6%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 10 |
DOI | Other Internet | 7 |
Figshare | Public | 2 |
Europe PMC | Domain | 1 |
Centre for Kidney Disease Research, Translational Research Institute, School of Medicine, University of Queensland, Australia - Journal of Kidney Cancer and VHL | Institution | 1 |